Navigation Links
Isis Reports Financial Results and Highlights for First Quarter 2013
Date:5/7/2013

t high-quality partners for our severe neurological disease and cancer programs to augment our own efforts in these two newest areas of our pipeline.  We have been successful implementing this strategy.  Since January of last year, we have initiated five new partnerships that involve neurological diseases and cancer, bringing in more than $125 million in upfront payments and adding partners that are significantly enhancing our drug discovery and development efforts in these therapeutic areas," continued Ms. Parshall.  "We believe that our partnerships are structured to provide the best support and ultimately the best value for each drug.  Our partnership with Roche for our Huntington's disease program is a very good example of how we benefit from the expertise and resources that our partner brings while we maintain control over the discovery and early development of the program.  We look forward to broadly evaluating this program with Roche and developing antisense drugs to treat Huntington's disease."Corporate and Drug Development Highlights

  • Isis and Genzyme were successful in bringing KYNAMRO to the market in the United States for patients with HoFH.  These patients are at high cardiovascular risk and may not be able to reduce their LDL-C sufficiently with currently available lipid-lowering therapies. 
  • Genzyme launched KYNAMRO in the United States for the treatment of patients with HoFH.
  • Isis received a $25 million milestone payment from Genzyme related to the marketing approval of KYNAMRO by the FDA.
  • Genzyme continues to enroll the FOCUS FH study, which is designed to provide 60-week safety and efficacy data in FH patients to support an additional regulatory filing.  Genzyme reached an agreement with the FDA on the design of the FOCUS FH study via a Special Protocol Assessment, or SPA.
  • Isis and its investigators reported positive data from a number of drugs in Isis' pipeline.
    '/>"/>

  • SOURCE Isis Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Perrigo Reports Record Revenue and Adjusted Earnings
    2. Discovery Labs Reports First Quarter 2013 Financial Results
    3. Endo Reports First Quarter Financial Results
    4. Landauer, Inc. Reports Fiscal 2013 Second Quarter Results
    5. Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013
    6. Soligenix Reports First Quarter 2013 Financial Results and Highlights Recent Accomplishments
    7. IRIDEX Reports 2013 First Quarter Results
    8. Masimo Reports First Quarter 2013 Financial Results
    9. Neurocrine Biosciences Reports First Quarter 2013 Results
    10. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
    11. Mylan Reports a 19% Increase in First Quarter 2013 Adjusted Diluted EPS to $0.62
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2015)... -- Quietly, sedately, Morocco,s pharmaceutical sector is ... industry is strong, with a well-developed base of local ... One place where the quality of Moroccan ... has quietly become the second largest African exporter of ... Indeed, Moroccan pharma companies have been making inroads as ...
    (Date:7/31/2015)... According to a new market ... Analyzers (BIA), Dual-Energy X-ray Absorptiometry (DEXA), Skinfold Calipers, Air ... & Forecast to 2019", published by MarketsandMarkets, the global ... 2014 and is estimated to grow to $1,425.7 Million ... 2014 to 2019. Browse 41 market ...
    (Date:7/30/2015)... 30, 2015 IRIDEX Corporation (NASDAQ: IRIX ... quarter 2015 financial results after the market closes on ... the release, the Company will host a conference call ... Time on Thursday, August 6, 2015 ... business developments. Interested parties may access the ...
    Breaking Medicine Technology:PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2
    ... June 16, 2011 The largest human dermal allograft available ... will be introduced at the AWR meeting here this week. ... is introducing FlexHD acellular hydrated dermal matrix 20 ... cm x 25 cm grafts. FlexHD ...
    ... our scope of services, Shenzhen Wuzhou Changlian International Trading ... with a city hospital in the Southeast of Africa soon, ... equipment. Wuzhou Changlian has offered specialty body-care products ... which puts a focus on meeting local people,s needs and ...
    Cached Medicine Technology:Largest Acellular Dermal Allografts Available for Abdominal Wall Reconstruction Introduced at AWR 2011 2Shenzhen Wuzhou Changlian International Trading Co. Establishes Relationship with Hospital in Africa 2
    (Date:7/31/2015)... ... July 31, 2015 , ... Sculpted Contours Luxury Medical Aesthetics announces the arrival ... Zeltiq Aesthetics released this new applicator in the United States as an upgrade to ... thighs. The original applicator required a 2 hour treatment time. The new ...
    (Date:7/31/2015)... Jacksonville, FL (PRWEB) , ... July 31, 2015 ... ... has announced an important workshop at its new True North Conference Center. The ... attend so that the Jacksonville community may be more aligned in the effort ...
    (Date:7/31/2015)... ... 2015 , ... Coco Libre announced today that their flagship Organic Coconut Water ... Vans US Open of Surfing, July 25 through August 2 in Huntington Beach, California. ... the market, is a natural choice given the Open’s commitment to sustainable practices. ...
    (Date:7/31/2015)... , ... July 31, 2015 , ... Ticket Down is ... Those looking to catch a new and refreshing show on Broadway, look no ... and achievements including an Obie Award, Outer Critics Circle Award, Drama Desk Award, Lucille ...
    (Date:7/31/2015)... ... July 31, 2015 , ... According to an article published ... if they could reach a consensus on the steps that need to be taken ... group reached 90 percent consensus on a series of steps that each surgeon must ...
    Breaking Medicine News(10 mins):Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3
    ... research and the potential use of human embryonic stem ... splits both scientific and public opinion. The current conflict ... with the ethical implications of this promising, but delicate ... its early stages of development. It is a symbolic ...
    ... Fla., June 25 Pharmavite, a ... chosen the on-line consumer-centric,program, LearnSomethingAbout(TM), as ... created the engaging, consumer-oriented multimedia,program that ... national retailers., "LearnSomething shares similar ...
    ... Dr. Hilton Becker M.D.,F.A.C.S., F.R.C.S. of Boca Raton, Florida, ... 20 years, has created his most effective,implant yet -- the ... adjust in both shape and size after it has been ... are disappointed with,the shape and size of the breast after ...
    ... full $25 million of required financing now ... 25 /PRNewswire-FirstCall/ - Bioniche Life Sciences,Inc. (TSX: ... announced that it has secured an amendment,to ... the Industrial,Technologies Office of Industry Canada that ...
    ... PARSIPPANY, N.J., June 25 DSM,Biologics and Crucell ... that they have entered into an agreement with ... Vendor Network. Under,the terms of the agreement, Avid ... of the PER.C6(R) cell line located in the,western ...
    ... pressure checks can help control hypertension without office visits, ... of more than 700 Group Health patients published in ... Association . , "To our knowledge, this is ... care and a patient-shared electronic medical record to improve ...
    Cached Medicine News:Health News:Stem cell research from an ethical point of view 2Health News:Pharmavite Partners With LearnSomething, Inc. on Consumer Education Program, LearnSomethingAbout(TM) 2Health News:Boca Raton Based Plastic Surgeon Introduces Revolutionary New Adjustable Breast Implant to Europe and Asia 2Health News:Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production 2Health News:Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production 3Health News:Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production 4Health News:DSM and Crucell Sign Agreement with Avid Bioservices to Serve as First Pre-Approved U.S. Contract Manufacturer of PER.C6(R) Cell Line Proteins 2Health News:DSM and Crucell Sign Agreement with Avid Bioservices to Serve as First Pre-Approved U.S. Contract Manufacturer of PER.C6(R) Cell Line Proteins 3Health News:DSM and Crucell Sign Agreement with Avid Bioservices to Serve as First Pre-Approved U.S. Contract Manufacturer of PER.C6(R) Cell Line Proteins 4Health News:DSM and Crucell Sign Agreement with Avid Bioservices to Serve as First Pre-Approved U.S. Contract Manufacturer of PER.C6(R) Cell Line Proteins 5Health News:New online care for hypertension gets results 2
    ... an integrated system that will perform venous ... it. You no longer need to manually ... inflow with and without reactive hyperemia are ... time for measurements and the frequency with ...
    ... of an exciting new range of ... Coherence Reflectometry) technology,our Slitlamp-mounted* Pachymeter offers ... and this non-contact.,This allows pachymetry ... time,and without concerns about sterilization, false ...
    ... The Paradigm Pachymetric Analyzer is designed ... employing unique digital signal processing algorithms. During ... a reading if the probe is +1.5 ... assured of highly accurate results, every time. ...
    ... a minimally invasive cryocatheter to treat ... a very high level of safety ... precision, minimal tissue disruption, and minimal ... is a flexible, single-use, minimally invasive ...
    Medicine Products: